Accession Digital Platform Hits 7-Year Development Milestone

Accession has announced that its digital platform pathwaypro® has hit 7 years of product development, completing a major goal set by the company 7 years ago. The platform allows healthcare organizations and decision-makers to model drug optimization and value-assessment. In a recent annual ranking of pharma companies in the UK, Accession was rated “one to watch”.

According to the company’s co-founder Lindsey Rosen, “pathwaypro® was born from Accession’s Market Access Innovators & Disruptors Movement which we launched in November 2015 and championed the need for genuine innovation in market access. We set in motion a 7-year plan of ongoing development, and here we are today, with a technology that has supported so much positive change across the NHS, and a technology that is now in perfect shape to support the NHS into 2023 and beyond with its most critical issues”

To read more, click here.

(Source: PM Live, November 18^th, 2022)